Catarina Träger

Publikationer
CV
Populärvetenskap och samverkan

Artiklar

Article: PEDIATRIC BLOOD AND CANCER. 2018;65(7):e27052
Event-free survival of infants and toddlers enrolled in the HR-NBL-1/SIOPEN trial is associated with the level of neuroblastoma mRNAs at diagnosis
Corrias MV; Parodi S; Tchirkov A; Lammens T; Vicha A; Pasqualini C; Trager C; Yanez Y; Dallorso S; Varesio L; Luksch R; Laureys G; Valteau-Couanet D; Canete A; Poeetschger U; Ladenstein R; Burchill SA
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2018;115(6):E1229-E1238
MYCN-amplified neuroblastoma maintains an aggressive and undifferentiated phenotype by deregulation of estrogen and NGF signaling
Dzieran J; Garcia AR; Westermark UK; Henley AB; Sanchez EE; Trager C; Johansson HJ; Lehtio J; Arsenian-Henriksson M
Article: JOURNAL OF CLINICAL ONCOLOGY. 2014;32(25):2727-2734
Emergence of New ALK Mutations at Relapse of Neuroblastoma
Schleiermacher G; Javanmardi N; Bernard V; Leroy Q; Cappo J; Frio TR; Pierron G; Lapouble E; Combaret V; Speleman F; de Wilde B; Djos A; Ora I; Hedborg F; Traeger C; Holmqvist B-M; Abrahamsson J; Peuchmaur M; Michon J; Janoueix-Lerosey I; Kogner P; Delattre O; Martinsson T
Article: BMC CANCER. 2013;13:231
Age dependence of tumor genetics in unfavorable neuroblastoma: arrayCGH profiles of 34 consecutive cases, using a Swedish 25-year neuroblastoma cohort for validation
Cetinkaya C; Martinsson T; Sandgren J; Trager C; Kogner P; Dumanski J; de Stahl TD; Hedborg F
Article: INTERNATIONAL JOURNAL OF CANCER. 2012;131(4):E555-E561
Hepatoblastoma in the Nordic countries
Licht SDF; Schmidt LS; Rod NH; Schmiegelow K; Lahteenmaki PM; Kogner P; Trager C; Stokland T; Schuz J
Article: PEDIATRIC BLOOD AND CANCER. 2011;56(1):65-69
Incidence of Childhood Central Nervous System Tumors in the Nordic Countries
Schmidt LS; Schmiegelow K; Lahteenmaki P; Trager C; Stokland T; Grell K; Gustafson G; Sehested A; Raashou-Nielsen O; Johansen C; Schuz J
Article: BRITISH JOURNAL OF CANCER. 2010;102(11):1670-1675
Infectious exposure in the first years of life and risk of central nervous system tumours in children: analysis of birth order, childcare attendance and seasonality of birth
Schmidt LS; Kamper-Jorgensen M; Schmiegelow K; Johansen C; Lahteenmaki P; Trager C; Stokland T; Grell K; Gustafson G; Kogner P; Sehested A; Schuz J
Article: CANCER EPIDEMIOLOGY, BIOMARKERS AND PREVENTION. 2010;19(4):1042-1052
Fetal Growth, Preterm Birth, Neonatal Stress and Risk for CNS Tumors in Children: A Nordic Population- and Register-Based Case-Control Study
Schmidt LS; Schuz J; Lahteenmaki P; Trager C; Stokland T; Gustafson G; Hjalgrim L; Sehested A; Johansen C; Schmiegelow K
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2010;107(9):4323-4328
High-risk neuroblastoma tumors with 11q-deletion display a poor prognostic, chromosome instability phenotype with later onset
Caren H; Kryh H; Nethander M; Sjoberg R-M; Trager C; Nilsson S; Abrahamsson J; Kogner P; Martinsson T
Article: INTERNATIONAL JOURNAL OF CANCER. 2008;123(12):2849-2855
mRNAs of tyrosine hydroxylase and dopa decarboxylase but not of GD2 synthase are specific for neuroblastoma minimal disease and predicts outcome for children with high-risk disease when measured at diagnosis
Trager C; Vernby A; Kullman A; Ora I; Kogner P; Kagedal B
Article: PIGMENT CELL AND MELANOMA RESEARCH. 2004;17(4):346-351
Pterin-dependent tyrosine hydroxylase mRNA is not expressed in human melanocytes or melanoma cells
Kågedal B; Kullman A; Lenner L; Träger C; Kogner P; Farnebäck M
Article: CLINICAL CHEMISTRY. 2003;49(1):104-112
Quantitative analysis of tyrosine hydroxylase mRNA for sensitive detection of neuroblastorna cells in blood and bone marrow
Träger C; Kogner P; Lindskog M; Ponthan F; Kullman A; Kågedal B

Alla övriga publikationer

Thesis / dissertation: 2009
Neuroblastoma incidence, biology and outcome : with special emphasis on quantitative analysis of tyrosine hydroxylase mRNA in blood and bone marrow
Träger, Catarina

Anställningar

Anknuten till Forskning, Kvinnors och barns hälsa, Karolinska Institutet, 2024-2027

Examina och utbildning

Medicine Doktorsexamen, Institutionen för kvinnors och barns hälsa, Karolinska Institutet, 2009

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI